XPO7-NPAT轴代表TP53突变急性髓性白血病的关键漏洞
Yuichiro Semba1, Takuji Yamauchi1, Daniel E Bauer2
1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Blood
|October 29, 2025
概括
发生TP53突变的急性髓性白血病 (AML) 耐治疗. 研究人员发现XPO7-NPAT通路驱动TP53突变AML的存活率,为这种侵袭性白血病提供了潜在的新治疗标.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 具有TP53突变的急性髓性白血病 (AML) 由于其对常规治疗的耐药性, presents一个重要的治疗挑战.
- 与这种AML亚型相关的不良临床结果凸显了对新型策略的迫切需要.
研究的目的:
- 确定TP53突变AML的新型治疗点.
- 阐明驱动TP53突变AML细胞生存和增殖的分子机制.
主要方法:
- 在同位素小鼠AML模型 (Trp53-野生型和淘汰赛) 中进行全基因组CRISPR/Cas9脱落选.
- 对老鼠和人类AML样本的转录和蛋白质组分析.
- 使用患者衍生异种移植 (PDX) 模型进行验证,并对公共AML数据集进行分析.
主要成果:
- 鉴定出了XPO7 (出口因7) -NPAT (核蛋白,基因组转录的联合激活剂) 途径对于TP53突变AML的生存至关重要.
- 在TP53突变的AML中,XPO7通过在核中保留NPAT来促进增殖,从而导致基因组损失和基因组不稳定.
- 增加的XPO7和NPAT表达是TP53-突变AML的特征,并在体内驱动白血病的进展.
结论:
- XPO7-NPAT通路是TP53突变的AML病变发生的关键驱动因素.
- 这一途径代表了对耐火TP53突变AML的显著漏洞和有前途的治疗标.
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K